Oscar Health (NYSE:OSCR) Trading 4.1% Higher – Here’s Why

Oscar Health, Inc. (NYSE:OSCR) shares were up 4.1% on Wednesday . The company traded as high as $15.18 and last traded at $14.98. Approximately 739,484 shares changed hands during trading, a decline of 67% from the average daily volume of 2,250,402 shares. The stock had previously closed at $14.39.

Analyst Upgrades and Downgrades

A number of research firms recently issued reports on OSCR. Jefferies Financial Group began coverage on shares of Oscar Health in a report on Tuesday, December 10th. They set an “underperform” rating and a $12.00 price objective for the company. UBS Group began coverage on shares of Oscar Health in a report on Monday, October 7th. They set a “neutral” rating and a $23.00 price objective for the company. Finally, Bank of America downgraded shares of Oscar Health from a “neutral” rating to an “underperform” rating and decreased their price objective for the stock from $21.00 to $13.50 in a report on Wednesday, November 6th. Two investment analysts have rated the stock with a sell rating, two have given a hold rating, four have issued a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $21.56.

Oscar Health Price Performance

The stock has a market cap of $3.49 billion, a PE ratio of -235.29 and a beta of 1.70. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.73 and a quick ratio of 0.73. The firm’s 50 day moving average price is $15.17 and its two-hundred day moving average price is $16.92.

Oscar Health (NYSE:OSCR) last posted its earnings results on Thursday, November 7th. The company reported ($0.22) earnings per share for the quarter, missing the consensus estimate of ($0.20) by ($0.02). The business had revenue of $2.42 billion during the quarter, compared to analysts’ expectations of $2.33 billion. Oscar Health had a return on equity of 2.79% and a net margin of 0.35%. Oscar Health’s revenue for the quarter was up 68.3% on a year-over-year basis. During the same quarter in the previous year, the business earned ($0.29) EPS. On average, research analysts expect that Oscar Health, Inc. will post -0.01 earnings per share for the current year.

Insider Activity at Oscar Health

In other Oscar Health news, Vice Chairman Joshua Kushner acquired 276,040 shares of the stock in a transaction that occurred on Monday, November 11th. The shares were bought at an average price of $13.58 per share, for a total transaction of $3,748,623.20. Following the completion of the transaction, the insider now owns 5,031,262 shares of the company’s stock, valued at approximately $68,324,537.96. This represents a 5.80 % increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CAO Victoria Baltrus sold 8,078 shares of the stock in a transaction on Monday, December 2nd. The shares were sold at an average price of $18.08, for a total value of $146,050.24. Following the completion of the transaction, the chief accounting officer now directly owns 146,036 shares in the company, valued at approximately $2,640,330.88. This represents a 5.24 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders bought 1,055,478 shares of company stock valued at $14,432,852 and sold 103,610 shares valued at $1,847,519. 25.11% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in the company. State Street Corp increased its stake in Oscar Health by 6.0% in the third quarter. State Street Corp now owns 5,132,802 shares of the company’s stock valued at $108,867,000 after acquiring an additional 291,335 shares during the last quarter. Geode Capital Management LLC increased its stake in Oscar Health by 11.7% in the third quarter. Geode Capital Management LLC now owns 4,339,640 shares of the company’s stock valued at $92,062,000 after acquiring an additional 455,205 shares during the last quarter. Renaissance Technologies LLC increased its stake in Oscar Health by 31.7% in the second quarter. Renaissance Technologies LLC now owns 3,886,100 shares of the company’s stock valued at $61,478,000 after acquiring an additional 934,600 shares during the last quarter. JPMorgan Chase & Co. increased its stake in Oscar Health by 68.5% in the third quarter. JPMorgan Chase & Co. now owns 2,309,150 shares of the company’s stock valued at $48,977,000 after acquiring an additional 938,742 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. increased its stake in Oscar Health by 20.3% in the third quarter. Charles Schwab Investment Management Inc. now owns 1,600,166 shares of the company’s stock valued at $33,940,000 after acquiring an additional 270,223 shares during the last quarter. Institutional investors own 75.70% of the company’s stock.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.